The advantages of VEGF inhibitors for ROP treatment, compared with laser treatment, include less time to administer treatment, less treatment-related destruction of the peripheral retina, and a lower likelihood of high myopia and astigmatism [10]. This evidence concerns the gene VEGFA and retinopathy of prematurity.